Ocular Therapeutix (OCUL) Raises $475M to Fund Phase 3 Axpaxli Trials
Ocular Therapeutix, Inc. (NASDAQ: OCUL) is a biopharmaceutical company dedicated to developing and commercializing innovative therapies for eye…
Browsing Tag